These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 5-Aminolevulinic acid/sodium ferrous citrate enhanced the antitumor effects of programmed cell death-ligand 1 blockade by regulation of exhausted T cell metabolism in a melanoma model. Hu X; Que W; Hirano H; Wang Z; Nozawa N; Ishii T; Ishizuka M; Ito H; Takahashi K; Nakajima M; Tanaka T; Zhu P; Guo WZ; Li XK Cancer Sci; 2021 Jul; 112(7):2652-2663. PubMed ID: 33934440 [TBL] [Abstract][Full Text] [Related]
4. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Scharping NE; Menk AV; Moreci RS; Whetstone RD; Dadey RE; Watkins SC; Ferris RL; Delgoffe GM Immunity; 2016 Aug; 45(2):374-88. PubMed ID: 27496732 [TBL] [Abstract][Full Text] [Related]
6. Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8 Hurst KE; Lawrence KA; Essman MT; Walton ZJ; Leddy LR; Thaxton JE Cancer Immunol Res; 2019 Mar; 7(3):476-486. PubMed ID: 30659052 [TBL] [Abstract][Full Text] [Related]
7. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models. Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930 [TBL] [Abstract][Full Text] [Related]
8. The cytokine Meteorin-like inhibits anti-tumor CD8 Jackson CM; Pant A; Dinalankara W; Choi J; Jain A; Nitta R; Yazigi E; Saleh L; Zhao L; Nirschl TR; Kochel CM; Hwa-Lin Bergsneider B; Routkevitch D; Patel K; Cho KB; Tzeng S; Neshat SY; Kim YH; Smith BJ; Ramello MC; Sotillo E; Wang X; Green JJ; Bettegowda C; Li G; Brem H; Mackall CL; Pardoll DM; Drake CG; Marchionni L; Lim M Immunity; 2024 Aug; 57(8):1864-1877.e9. PubMed ID: 39111315 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia Induces Mitochondrial Defect That Promotes T Cell Exhaustion in Tumor Microenvironment Through MYC-Regulated Pathways. Liu YN; Yang JF; Huang DJ; Ni HH; Zhang CX; Zhang L; He J; Gu JM; Chen HX; Mai HQ; Chen QY; Zhang XS; Gao S; Li J Front Immunol; 2020; 11():1906. PubMed ID: 32973789 [TBL] [Abstract][Full Text] [Related]
10. Disturbed mitochondrial dynamics in CD8 Yu YR; Imrichova H; Wang H; Chao T; Xiao Z; Gao M; Rincon-Restrepo M; Franco F; Genolet R; Cheng WC; Jandus C; Coukos G; Jiang YF; Locasale JW; Zippelius A; Liu PS; Tang L; Bock C; Vannini N; Ho PC Nat Immunol; 2020 Dec; 21(12):1540-1551. PubMed ID: 33020660 [TBL] [Abstract][Full Text] [Related]
11. Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Lopes N; McIntyre C; Martin S; Raverdeau M; Sumaria N; Kohlgruber AC; Fiala GJ; Agudelo LZ; Dyck L; Kane H; Douglas A; Cunningham S; Prendeville H; Loftus R; Carmody C; Pierre P; Kellis M; Brenner M; Argüello RJ; Silva-Santos B; Pennington DJ; Lynch L Nat Immunol; 2021 Feb; 22(2):179-192. PubMed ID: 33462452 [TBL] [Abstract][Full Text] [Related]
12. KDM3A Senses Oxygen Availability to Regulate PGC-1α-Mediated Mitochondrial Biogenesis. Qian X; Li X; Shi Z; Bai X; Xia Y; Zheng Y; Xu D; Chen F; You Y; Fang J; Hu Z; Zhou Q; Lu Z Mol Cell; 2019 Dec; 76(6):885-895.e7. PubMed ID: 31629659 [TBL] [Abstract][Full Text] [Related]
13. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity. Gu M; Zhou X; Sohn JH; Zhu L; Jie Z; Yang JY; Zheng X; Xie X; Yang J; Shi Y; Brightbill HD; Kim JB; Wang J; Cheng X; Sun SC Nat Immunol; 2021 Feb; 22(2):193-204. PubMed ID: 33398181 [TBL] [Abstract][Full Text] [Related]
14. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8 Yin W; Song Y; Liu Q; Wu Y; He R Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970 [TBL] [Abstract][Full Text] [Related]
15. P2X7 Receptor Activity Limits Accumulation of T Cells within Tumors. Romagnani A; Rottoli E; Mazza EMC; Rezzonico-Jost T; De Ponte Conti B; Proietti M; Perotti M; Civanelli E; Perruzza L; Catapano AL; Baragetti A; Tenedini E; Tagliafico E; Falzoni S; Di Virgilio F; Norata GD; Bicciato S; Grassi F Cancer Res; 2020 Sep; 80(18):3906-3919. PubMed ID: 32699136 [TBL] [Abstract][Full Text] [Related]
16. STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment. Chelvanambi M; Fecek RJ; Taylor JL; Storkus WJ J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33526609 [TBL] [Abstract][Full Text] [Related]